BNGO Nov 2024 1.000 call
| Previous Close | 0.0100 |
| Open | 0.0100 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 1.00 |
| Expire Date | 2024-11-15 |
| Day's Range | 0.0100 - 0.0100 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
ZacksBears are Losing Control Over Bionano Genomics (BNGO), Here's Why It's a 'Buy' Now
Bionano Genomics (BNGO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
GlobeNewswireBionano to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
SAN DIEGO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the H.C. Wainwright 26th Annual Global Investment Conference on Monday, September 9th, 2024. Conference & Webcast Details Date:September 9, 2024Time:11:00 a.m. to 11:30 a.m. ETPresenter:Erik Holmlin, PhD, CEO of BionanoWebcast:Link to Register A replay / recording of the session will be available following the
ZacksBionano Genomics (BNGO) Upgraded to Buy: Here's Why
Bionano Genomics (BNGO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
